Clinical Trial

Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

Study acronym: HARMONY
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-16
notable Trial sites expanded: 0 -> 7 locations 2026-04-16
Trial Details
NCT Number NCT07258069
Lead Sponsor Aesculap AG
Conditions Subdural Hematoma, Subdural Hematoma, Chronic
Enrollment 178 participants
Start Date 2026-04-10
Primary Completion 2026-12 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-17